Oxidative Stress In Cultured Renal Tubular Cells (DOI:10.1016/j.juro.2007.11.039);Reduction of Oxidative Stress in Cultured Renal Tubular Cells and Preventive Effects on Renal Stone Formation by the Bioflavonoid Quercetin

Journal of Urology

Volumn 179, Issue 4, 2008, Pages 1620-1626

  Park, Hyoung Keun ^a   Jeong, Byong Chang ^b   Sung, Mi Kyung ^d   Park, Mi Young ^d   Choi, Eun Young ^c   Kim, Bong Sub ^c   Kim, Hyeon H ^b,c   Kim, Jeong In ^e  

^a Dongguk University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Sookmyung Women's University   (South Korea)

^e Inje University   (South Korea)

Author keywords

antioxidants; kidney; kidney calculi; quercetin; rats; Sprague Dawley

Indexed keywords

CALCIUM OXALATE; CATALASE; GENTAMICIN; MALONALDEHYDE; OXALATE SODIUM; OXALIC ACID DERIVATIVE; QUERCETIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL VIABILITY; COMPARATIVE STUDY; CONTROLLED STUDY; CRYSTALLIZATION; ENZYME ACTIVITY; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; LIPID PEROXIDATION; MALE; MICROSCOPY; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STONE FORMATION;

EID: 40849095966     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.05.035     Document Type: Erratum

References (26)

1. Scheid C.R., Koul H., and Hill W.A. Oxalate ion and calcium oxalate crystal interactions with renal epithelial cells. In: Coe F.L., Favus M.J., Pak C.Y., Parks J.H., and Preminger G.M. (Eds). Kidney Stones: Medical and Surgical Management (1996), Lippincott-Raven, Philadelphia 129 chapt 43
2. Finlayson B., Khan S.R., and Hackett R. Mechanisms of stone formation-an overview. Scan Electron Microsc 3 (1984) 1419
3. Hackett R.L., Shevock P.N., and Khan S.R. Madin-Darby canine kidney cells are injured by exposure to oxalate and to calcium oxalate crystals. Urol Res 22 (1994) 197
4. Kumar S., Sigmon D., Miller T., Carpenter B., Khan S., Malhotra R., et al. A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 146 (1991) 1384
5. Kwak C., Jeong B.C., Kim S.W., and Kim H.H. The effect of oxalate on the growth of renal tubular epithelial cells. J Endourol 16 (2002) 261
6. Selvam R. Calcium oxalate stone disease: role of lipid peroxidation and antioxidants. Urol Res 30 (2002) 35
7. Thamilselvan S., Khan S.R., and Menon M. Oxalate and calcium oxalate mediated free radical toxicity in renal epithelial cells: effect of antioxidants. Urol Res 31 (2003) 3
8. Thamilselvan S., and Menon M. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status. BJU Int 96 (2005) 117
9. Itoh Y., Yasui T., Okada A., Tozawa K., Hayashi Y., and Kohri K. Preventive effects of green tea on renal stone formation and the role of oxidative stress in nephrolithiasis. J Urol 173 (2005) 271
10. Jeong B.C., Kim B.S., Kim J.I., and Kim H.H. Effects of green tea on urinary stone formation: an in vivo and in vitro study. J Endourol 20 (2006) 356
11. Santhosh Kumar M., and Selvam R. Supplementation of vitamin E and selenium prevents hyperoxaluria in experimental urolithic rats. J Nutr Biochem 14 (2003) 306
12. Formica J.V., and Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33 (1995) 1061
13. Robak J., and Gryglewski R.J. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 37 (1988) 837
14. Terao J., Piskula M., and Yao Q. Protective effect of epicatechin, epicatechin gallate and quercetin on lipid peroxidation in phospolipid bilayers. Arch Biochem Biophys 308 (1994) 278
15. Kuhlmann M.K., Horsch E., Burkhardt G., Wagner M., and Kohler H. Reduction of cisplatin toxicity in cultured renal tubular cells by the bioflavonoid quercetin. Arch Toxicol 72 (1998) 536
16. Singh D., Chander V., and Chopra K. The effect of quercetin, a bioflavonoid on ischemia/reperfusion induced renal injury in rats. Arch Med Res 35 (2004) 484
17. Wong S.H., Knight J.A., Hopfer S.M., Zaharia O., Leach Jr. C.N., and Sundeman Jr. F.H. Lipoperoxides in plasma as measured by liquid-chromatographic separation of malondialdehyde-thiobarbituric acid adduct. Clin Chem 33 (1987) 214
18. Jaffe M. Uber den niederschlag, welchen picrinsaure in normalen harn erzeugt und uber eine neue reaction des keratinins. Hoppe Zeylersz Physiol Chem 10 (1886) 391
19. Dance N., Price R.G., Robinson D., and Stirling J.L. Beta galactosidase, beta-glucosidase and N-acetyl-beta-glucosaminidase in human kidney. Clin Chim Acta 24 (1969) 189
20. Chiriboga J. Purification and properties of oxalic acid oxidase. Arch Biochem Biophys 116 (1966) 516
21. Toftegaard Nielsen T. A method for enzymatic determination of citrate in serum and urine. Scand J Clin Lab Invest 36 (1976) 513
22. Cohen S.A., and Sideman L. Modification of the o-cresolphthalein complexone method for determining calcium. Clin Chem 25 (1979) 1519
23. Zhang J., Stanley R.A., Adaim A., Melton L.D., and Skinner M.A. Free radical scavenging and cytoprotective activities of phenolic antioxidants. Mol Nutr Food Res 50 (2006) 996
24. Molina M.F., Sanchez-Reus I., Iglesias I., and Benedi J. Quercetin, a flavonoid antioxidant, prevents and protects against ethanol-induced oxidative stress in mouse liver. Biol Pharm Bull 26 (2003) 1398
25. Anjaneyulu M., and Chopra K. Quercetin, an anti-oxidant bioflavonoid, attenuates diabetic nephropathy in rats. Clin Exp Pharmacol Physiol 31 (2004) 244
26. Choi E.J., Chee K.M., and Lee B.H. Anti- and prooxidant effects of chronic quercetin administration in rats. Eur J Pharmacol 482 (2003) 281